Leadership Overview
Shilpa Medicare has 5 executives leading key functions including finance, operations, human resources, biopharma CDMO licensing, and CDMO business.
Driven by innovation, Shilpa Medicare is dedicated to advancing pharmaceutical manufacturing through its diverse portfolio of APIs, intermediates, and formulations, impacting global healthcare with its specialized offerings and contract manufacturing capabilities.
Driven by innovation, Shilpa Medicare is dedicated to advancing pharmaceutical manufacturing through its diverse portfolio of APIs, intermediates, and formulations, impacting global healthcare with its specialized offerings and contract manufacturing capabilities.
Leadership Roles at Shilpa Medicare
Pankaj Jhawar - Chief Financial Officer
Pankaj Jhawar, the Chief Financial Officer at Shilpa Medicare, directs the company's financial strategy and operations. Jhawar oversees all fiscal activities, including budgeting, financial planning, and risk management, ensuring the financial health and stability of the organization. This leadership role involves managing capital allocation, optimizing financial performance, and driving profitability across all business segments, from API manufacturing to formulations. Jhawar's expertise is critical in navigating the complex financial landscape of the pharmaceutical industry, supporting international expansion and investment in new drug delivery systems. The Chief Financial Officer ensures compliance with all financial regulations and reporting standards, providing essential insights for strategic decision-making. Pankaj Jhawar's stewardship guides Shilpa Medicare's financial trajectory, supporting its growth in oncology and non-oncology products.
Vellaian Karuppiah - Chief Operating Officer
Vellaian Karuppiah, the Chief Operating Officer at Shilpa Medicare, orchestrates the company's manufacturing and operational efficiency. Karuppiah oversees the end-to-end production processes for active pharmaceutical ingredients (APIs), intermediates, and finished formulations, ensuring high standards of quality and compliance. This role is pivotal in managing the supply chain, optimizing production schedules, and implementing advanced manufacturing technologies across facilities in India and internationally. The Chief Operating Officer drives operational excellence, focusing on cost-effectiveness and timely delivery of products, including specialized oncology and non-oncology APIs. Vellaian Karuppiah's leadership ensures the seamless execution of contract manufacturing for diverse dosage forms, from tablets to sterile injectables, supporting Shilpa Medicare's global market presence and commitment to pharmaceutical innovation.

Harshawardhan Bal - President, Biopharma Cdmo Licensing & Partnering (Ai Ml Discovery Development & Manufacturing)
Harshawardhan Bal, the President, Biopharma CDMO Licensing & Partnering (AI ML Discovery Development & Manufacturing) at Shilpa Medicare, spearheads the strategic growth and innovation within the biopharmaceutical contract development and manufacturing organization (CDMO) sector. Bal focuses on forging key licensing agreements and partnerships, leveraging artificial intelligence and machine learning to accelerate drug discovery, development, and manufacturing processes. This leadership position involves identifying and securing collaborations that enhance Shilpa Medicare's capabilities in complex biologics and peptide-based products. Harshawardhan Bal drives the integration of cutting-edge technologies to optimize the CDMO service offering, ensuring clients receive advanced solutions for their pharmaceutical needs. The President's efforts are crucial for expanding Shilpa Medicare's footprint in the global biopharma market through strategic alliances and technological advancements.
Harsh Bal - President, Cdmo Business (North America )
Harsh Bal, the President, CDMO Business (North America) at Shilpa Medicare, directs the expansion and operational success of the company's contract development and manufacturing organization services within the North American market. Bal is responsible for driving business growth, managing client relationships, and ensuring the delivery of high-quality pharmaceutical manufacturing solutions across the region. This role involves overseeing the strategic development of CDMO offerings, including specialized dosage forms and sterile injectables, to meet the specific demands of North American pharmaceutical and biotech companies. The President's focus is on enhancing Shilpa Medicare's market penetration and competitive positioning through superior service and product quality. Harsh Bal's leadership ensures alignment with regional market trends and regulatory requirements, solidifying Shilpa Medicare's reputation as a trusted CDMO partner in North America.
Pv Rao - Chief Human Resources Officer
Pv Rao, the Chief Human Resources Officer at Shilpa Medicare, leads the strategic development and execution of human capital initiatives. Rao is responsible for talent acquisition, employee development, and fostering a positive organizational culture across Shilpa Medicare's global operations. This critical function ensures the company attracts and retains top talent, essential for driving innovation in pharmaceutical manufacturing and research. The Chief Human Resources Officer oversees employee relations, compensation and benefits, and performance management systems, aligning HR strategies with the company's business objectives. Pv Rao's focus on workforce planning and organizational design supports Shilpa Medicare's expansion into new drug delivery systems and biotech products, ensuring a skilled and motivated team is in place to meet market demands and maintain operational excellence.
Explore Leadership Teams in Manufacturing
Founded in 1907 and headquartered in Vadodara, India, Alembic Limited is an integrated pharmaceutical company. The Company's products include active pharmaceutical ingredients, bulk pharmaceuticals, international and domestic formulations, herbals and nutraceuticals, and veterinary.
Company Leadership EP
WQ
PY
JM
Jubilant Pharmova is a patient-focused biopharmaceutical company based in Noida, India.
Company Leadership VK
SB
AR
HV
Madrigal Pharmaceuticals, Inc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. The company's lead candidate is MGL-3196, an orally administered, small-molecule, liver-directed, thyroid hormone receptor (THR) -selective agonist, which is in Phase II clinical trials for the treatment of non-alcoholic steatohepatitis and heterozygous familial hypercholesterolemia.
Company Leadership
JJ
SK
RF
Shionogi & Co., Ltd. is a Japanese pharmaceutical company dedicated to developing innovative treatments that improve patient lives worldwide. With a longstanding focus on addressing pressing global health challenges, the company has been a pioneer in discovering and delivering novel therapies for infectious diseases, including antibiotics, HIV, influenza, and emerging viral threats such as COVID-19. Shionogi combines in-house research and development with strategic collaborations across industry, government agencies, biotech companies, and academic institutions to accelerate the advancement of its scientific programs and bring meaningful therapies to patients with urgency and precision.
Company Leadership
TK
TN
